Ixekizumab
Taltz (ixekizumab) is a prescription biologic medication used to treat certain autoimmune conditions by targeting inflammation in the body. It is primarily prescribed for adults and children with moderate to severe plaque psoriasis, as well as adults with psoriatic arthritis and axial spondyloarthritis. This medication is administered as a subcutaneous injection and works by suppressing specific pathways in the immune system.
Taltz is an injectable biologic that treats autoimmune conditions like psoriasis and arthritis by blocking interleukin-17A to reduce inflammation.
Key facts at a glance
- RxNorm
- 1745104
- Generic
- Taltz
- Class
- brand-name
- Brands
- —
- Availability
- rx
- Lactation
- unknown
- Routes
- —
- Forms
- —
- Regions
- US, EU, CN, JP
- Monitoring
- —
This page is for informational purposes only.
Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.
Taltz is FDA-approved for treating moderate to severe plaque psoriasis in adults and children (ages 6 and older), psoriatic arthritis in adults, ankylosing spondylitis, and non-radiographic axial spondyloarthritis. It is typically prescribed when other treatments have not been effective or are not suitable.
Taltz is a monoclonal antibody that specifically binds to and neutralizes interleukin-17A (IL-17A), a protein that plays a key role in driving inflammation in autoimmune diseases. By blocking IL-17A, it helps reduce the overactive immune response that causes symptoms like skin plaques and joint pain.
Taltz increases the risk of serious infections, including tuberculosis and fungal infections. Patients should be screened for infections and tuberculosis before starting treatment. Common side effects include injection site reactions, upper respiratory infections, and cold symptoms. Live vaccines should be avoided during treatment. This medication may not be suitable during pregnancy or breastfeeding—patients should discuss their health history with their doctor.
Official drug label
WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 9, 2026. · Read our editorial policy